Venture Capital For MedTech “Somewhat Resilient,” With 18% Drop In ’08
This article was originally published in The Gray Sheet
Executive Summary
The U.S. medical technology industry's access to private venture capital remained relatively strong in 2008, while its ability to raise funds through debt and public stock offerings took a beating from the global financial crisis, according to a recent 1report by consulting firm Ernst & Young
You may also be interested in...
Despite Recession, Good Technologies Can Still Find Investors, Pros Say
The economic recession has reduced investment in start-up medical device companies, but promising ideas shepherded by excellent managers can still find investors, according to a panel of experts at the recent Design of Medical Devices conference in Minneapolis
Despite Recession, Good Technologies Can Still Find Investors, Pros Say
The economic recession has reduced investment in start-up medical device companies, but promising ideas shepherded by excellent managers can still find investors, according to a panel of experts at the recent Design of Medical Devices conference in Minneapolis
Uncertainties Threaten Venture-Capital-Backed Device Firms, MDMA Says
Policy-makers can protect device manufacturers' access to venture capital by tackling regulatory uncertainties that interfere with VC firms' exit strategies, according to a report by the Medical Devices Manufacturers Association and the National Venture Capital Association